Development of the ECDC Testing Guidance for hepatitis B, hepatitis C and HIV

Project Period

In 2016, ECDC commissioned an update to the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union published in December 2010 which HIV in Europe was contracted to do. The aim of the update was to develop an evidence-based public health guidance to provide EU/EEA countries with an evidence-based framework to support the further development of integrated national HBV, HCV, and HIV testing policies in the EU/EEA. The integrated guidance will be published in late 2018.


Main Partners
L Combs, S Finne Jakobsen, D Raben, CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
I Veldhuijzen, Dutch National Institute for Public Health and the Environment (RIVM), Netherlands
M Dutarte, M Vincente, European AIDS Treatment Group, Brussels, Belgium
L Tavoschi, European Centre for Disease Prevention and Control, Stockholm, Sweden
Y Yazdanpanah, INSERM, Paris, France
A van Ahee, E Bunge, L Mason, Pallas Health Research and Consultancy, Rotterdam, Netherlands
S Croxford, V Delpech, S Desai, Public Health England, London, United Kingdom
C Rae, M Rayment, A Sullivan, St. Stephen’s AIDS Trust, London, United Kingdom 

Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases
Section 2100, Finsencentret
Blegdamsvej 9
DK-2100 Copenhagen Ø
Tel: +45 35 45 57 57
Fax: +45 35 45 57 58


Ann Isabelle von Lingen, Policy Officer
European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium
Tel 32 2 626 96 41
M+32 491348317
Fax 32 2 644 33 07